Modulation of the Gut Microbiota and Metabolism in Elderly by Algae Products.
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Mar 18, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
This study aims to evaluate the effects of fermented black soybean and adlay supplements on frailty and gut microbiota in older adults. Older participants are recruited from National Taiwan University Hospital. Parcitipants will be stratified randomization into placebo and experimental groups based on their robustness status. Older participants will take either the fermented black soybean and adlay supplement or a placebo daily for 12 weeks. Baseline characteristics of the participants, including demographic data, chronic disease history, and anthropometric data, will be collected. Cognitiv...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 65 years or older
- • Independent in activities of daily living
- Exclusion Criteria:
- • Being bedridden or residing in a nursing home
- • Having a life expectancy of less than 6 months
- • Having severe hearing or communication disorders
- • Having hyperuricemia, gouty arthritis, or swallowing dysfunction
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported